BW 245C
CAS: 72814-32-5
Ref. 3D-XCA81432
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
- 4-Imidazolidineheptanoic acid, 3-(3-cyclohexyl-3-hydroxypropyl)-2,5-dioxo-, (R*,S*)-
- 4-Imidazolidineheptanoic acid, 3-[(3R)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo-, (4S)-rel-
- 4-Imidazolidineheptanoic acid, 3-[(3S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo-, (4R)-rel-
- 4-imidazolidineheptanoic acid, 3-[(3R)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo-, (4S)-
- Bw 245C
- rel-(4R)-3-[(3S)-3-Cyclohexyl-3-hydroxypropyl]-2,5-dioxo-4-imidazolidineheptanoic acid
BW 245C is a synthetic, nonsteroidal compound that binds to the 2-adrenergic receptor, thereby inhibiting its function. BW 245C has shown efficacy in reducing inflammation and pain in animal models of inflammatory bowel disease. This drug also inhibits prostaglandin production by binding to cyclooxygenase-2 (COX-2) and blocks the synthesis of basic protein. BW 245C has been found to be effective against human osteosarcoma cell lines with a polymerase chain reaction (PCR) assay and showed anti-inflammatory cytokine il-10 activity in vivo.
Chemical properties
Technical inquiry about: 3D-XCA81432 BW 245C
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
